These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2860743)

  • 1. Quantity of dengue virus required to infect rhesus monkeys.
    Kraiselburd E; Gubler DJ; Kessler MJ
    Trans R Soc Trop Med Hyg; 1985; 79(2):248-51. PubMed ID: 2860743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies.
    Kraiselburd EN; Lavergne JA; Woodall JP; Kessler MJ; Meier G; Chiriboga J; Moore CG; Sather GE; Pomales A; Maldonado E; Rivera R
    Infect Immun; 1981 Aug; 33(2):389-94. PubMed ID: 7024129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of viraemia and limited antibody response of dengue virus immune rhesus monkeys after vaccination with DEN-2/S-1 vaccine.
    Kraiselburd E; Kessler MJ; Torres-Blasini G
    Trans R Soc Trop Med Hyg; 1984; 78(4):445-8. PubMed ID: 6548325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels.
    Halstead SB; Diwan AR; Marchette NJ; Palumbo NE; Srisukonth L
    Am J Trop Med Hyg; 1984 Jul; 33(4):654-65. PubMed ID: 6476212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovirulence detection of dengue virus using rhesus and cynomolgus monkeys.
    Angsubhakorn S; Moe JB; Marchette NJ; Latendresse JR; Palumbo NE; Yoksan S; Bhamarapravati N
    J Virol Methods; 1987 Oct; 18(1):13-24. PubMed ID: 3693516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue-2 vaccine: viremia and immune responses in rhesus monkeys.
    Scott RM; Nisalak A; Eckels KH; Tingpalapong M; Harrison VR; Gould DJ; Chapple FE; Russell PK
    Infect Immun; 1980 Jan; 27(1):181-6. PubMed ID: 6766903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovirulence effects of dengue-2 viruses on the rhesus (Macaca mulatta) brain and spinal cord.
    Angsubhakorn S; Moe JB; Marchette NJ; Palumbo NE; Yoksan S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):52-5. PubMed ID: 3660068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
    Halstead SB; Eckels KH; Putvatana R; Larsen LK; Marchette NJ
    Am J Trop Med Hyg; 1984 Jul; 33(4):679-83. PubMed ID: 6476215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys.
    Freire M; Marchevsky R; Almeida L; Yamamura A; Caride E; Brindeiro P; Motta M; Nogueira R; Kubelka C; Bonaldo M; Galler R
    Mem Inst Oswaldo Cruz; 2007 May; 102(2):203-8. PubMed ID: 17426886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys.
    Angsubhakorn S; Yoksan S; Bhamarapravati N; Moe JB; Marchette NJ; Pradermwong A; Sahaphong S
    Trans R Soc Trop Med Hyg; 1988; 82(5):746-9. PubMed ID: 3252595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R; Larsen LK
    Am J Trop Med Hyg; 1984 Jul; 33(4):672-8. PubMed ID: 6476214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys.
    Men R; Bray M; Clark D; Chanock RM; Lai CJ
    J Virol; 1996 Jun; 70(6):3930-7. PubMed ID: 8648730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates.
    Harrison VR; Eckels KH; Sagartz JW; Russell PK
    Infect Immun; 1977 Oct; 18(1):151-6. PubMed ID: 409682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
    Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood value changes in flavivirus-inoculated Macaca fascicularis monkeys.
    Angsubhakorn S; Yoksan S; Henchal EA; Nisalak A; Hoke CH; Pradermwong A; Sahaphong S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):1-7. PubMed ID: 2874612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
    Pletnev AG; Swayne DE; Speicher J; Rumyantsev AA; Murphy BR
    Vaccine; 2006 Sep; 24(40-41):6392-404. PubMed ID: 16831498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.